 |
| Lysosome with sphingolipids |
 |
| Fabry Disease |
What was once classified as a rare disease, is now becoming an epidemic in 1 in 1500 to 3000 people of Alberta, Canada. This disease is called Fabry disease. According to the Faculty of Medicine and Dentistry, “Fabry disease is a genetic metabolic condition that destroys the enzyme involved in fat metabolism.” When fat deposits accumulate in the body, it affects the heart, kidneys, and brain. Gavin Oudit had stated, “heart disease is the number one cause of death for patients with Fabry disease.” When you use an MRI or ultrasound to detect whether or not your body has been affected from the disease, sometimes this condition could look like other diseases. Richard Thompson and Kelvin Chow have developed a new system that better detects the damages and changes in early stages. This new MRI technique is called T1 mapping. The difference between T1 mapping and MRI/ultrasound is the scans can detect both the disease and severity of damage to the heart. This new technique can easily be programmed into MRI systems around the world and hopefully provide other advancements to detect other disease conditions.
http://www.geneticdiseasefoundation.org/genetic-diseases/fabry-disease/?_kk=fabry%20disease&_kt=accdb0de-692e-4bce-8e8d-02be219b6310&gclid=CL6M95jSgLoCFYOk4Aod8QwAUQ
